Ana-Maria Orbai, MD, MHS, on Measuring Minimal Disease Activity in Psoriatic Arthritis
A team of researchers recently evaluated whether the Health Assessment Questionnaire\u2010Disability Index (HAQ-DI) is interchangeable with the Patient\u2010Reported Outcomes Measurement Information System\u2010Physical Function (PROMIS-PF) when measuring minimal disease activity (MDA) among patients with psoriatic arthritis (PsA). The findings showed that there is \u201cexcellent agreement\u201d between HAQ\u2010DI and PROMIS\u2010based MDA definitions statically and longitudinally. In this podcast, study coauthor Ana-Maria Orbai, MD, MHS, talks about her team\u2019s findings and how they may influence the way you calculate MDA. For more information, visit: https://www.consultant360.com/rheumatology.